• Citer

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)

par Pritchard, Kathleen;Rolski, Janusz;Papai, Zsuzsanna;Mauriac, Louis;Cardoso, Fatima ;Chang, Jose;Panasci, Lawrence;Ianuli, Carmen;Kahan, Zsuzsanna;Fukase, Kenjiro;Lindemann, Justin;MacPherson, Merran M.P.;Neven, Patrick
Référence Breast cancer research and treatment, 123, 2, page (453-461)
Publication Publié, 2010-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
Auteur:	Pritchard, Kathleen; Rolski, Janusz; Papai, Zsuzsanna; Mauriac, Louis; Cardoso, Fatima; Chang, Jose; Panasci, Lawrence; Ianuli, Carmen; Kahan, Zsuzsanna; Fukase, Kenjiro; Lindemann, Justin; MacPherson, Merran M.P.; Neven, Patrick
Informations sur la publication:	Breast cancer research and treatment, 123, 2, page (453-461)
Statut de publication:	Publié, 2010-09
Sujet CREF:	Cancérologie
Mots-clés:	Advanced breast cancer
	Endocrine
	Faslodex
	Fulvestrant
	High dose
	Loading dose
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-010-1022-9
	info:scp/77956164319
	info:pmid/20632084